Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19855604 | 0.96 | TSHR (0.41) | TSHRMAPT | |
| SCHEMBL19855589 | 0.90 | TSHR (0.33) | TSHR | |
| SCHEMBL19853821 | 0.88 | TSHR (0.41) | TSHRMAPT | |
| SCHEMBL19853815 | 0.87 | MAPT (0.35) | TSHRMAPT | |
| SCHEMBL19855583 | 0.85 | TSHR (0.35) | TSHRMAPT | |
| SCHEMBL19856080 | 0.84 | TSHR (0.44) | TSHRMAPT | |
| SCHEMBL19855721 | 0.84 | TSHR (0.38) | TSHRMAPT | |
| SCHEMBL19855587 | 0.83 | — | — | |
| SCHEMBL19856251 | 0.83 | TSHR (0.37) | TSHR | |
| SCHEMBL20882519 | 0.83 | TSHR (0.34) | TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-10982146-B2 | Liquid crystal composition, liquid crystal element, and use of liquid crystal composition in liquid crystal element | JNC CORPORATION (JP) | 2021-04-20 | — | — | US | disclosed |
| US-10428275-B2 | Method for manufacturing liquid crystal display device and liquid crystal display device | JNC CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| US-20190225886-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND USE OF LIQUID CRYSTAL COMPOSITION IN LIQUID CRYSTAL ELEMENT | JNC CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| US-20190225887-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| EP-3466918-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2019-04-10 | — | — | EP | disclosed |
| WO-2018025974-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE | JNC株式会社 | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | SP1, PYM1, MPEG1 | TSHR 3095/4885MAPT 2338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.